Compare ZDGE & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZDGE | VNRX |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | United States |
| Employees | 81 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.6M | 38.2M |
| IPO Year | N/A | N/A |
| Metric | ZDGE | VNRX |
|---|---|---|
| Price | $3.27 | $0.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 2.7M | ★ 3.5M |
| Earning Date | 12-12-2025 | 11-13-2025 |
| Dividend Yield | ★ 2.10% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $29,814,000.00 | $1,472,007.00 |
| Revenue This Year | $2.37 | $55.33 |
| Revenue Next Year | $4.54 | $493.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 14.48 |
| 52 Week Low | $1.73 | $0.23 |
| 52 Week High | $4.89 | $0.94 |
| Indicator | ZDGE | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 68.78 | 35.84 |
| Support Level | $2.72 | $0.25 |
| Resistance Level | $4.70 | $0.30 |
| Average True Range (ATR) | 0.37 | 0.03 |
| MACD | 0.10 | 0.00 |
| Stochastic Oscillator | 43.44 | 27.38 |
Zedge Inc builds digital marketplaces and competitive games centered on content that people use for self-expression. Its products include the Zedge App, a freemium digital content marketplace offering mobile wallpapers, video wallpapers, ringtones, and notification sounds, along with pAInt, a generative AI wallpaper and ringtone maker, GuruShots, a skill-based photo challenge game, and Emojipedia, a trusted source for emoji information. The Zedge App is available on Google Play and the App Store. The company operates two segments: Zedge Marketplace and GuruShots, with the majority of revenue generated from the Zedge Marketplace.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.